Dose Exploration Study of GSK4532990 in Participants With NASH or Suspected NASH

Conditions: Non-alcoholic Fatty Liver Disease Interventions: Drug: GSK4532990 Sponsors: GlaxoSmithKline Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials